SEBI has sought explanations from Borderless, formerly Stockal, over unauthorised trades in US stocks on its platform on October 15. The company has substantially responded to SEBI's queries, and its first priority is now to restore affected investors' portfolios to their positions before the incident, a Borderless spokesperson told NDTV Profit.
@nizzgeneration
https://t.co/k15IcISdN8
Bombay HC will hear NMS Health founder BR Shetty's 1500 crore damages suit against Bank of Baroda on November 19.
Shetty's lawyers mentioned the matter in court today and said they will be pressing urgent reliefs including production of documents and provisioning of 1500 crores in BoB's books.
Court said notice to be given to BoB, matter to be taken up on 19th November.
Sun Pharma lawyers: Product outside the range covered by Novo Nordisk patent
Two tests reports placed on record, including one from IIT
Court observes: Manufacturers outside the Novo Nordisk patented range should be allowed to manufacture semaglutide oral drugs
Court: Novo Nordisk to reply to Sun Pharma application to allow manufacturing
Matter listed for December 9
Novo Nordisk v Sun Pharma semaglutide patent battle in Delhi HC:
Sun Pharma files application to allow manufacture and launch of generic oral semaglutide
Alert: Sun Pharma was to seek permission of court before launch of the drug after receiving marketing approval
#Breaking Ministry of Civil Aviation floats Draft SAF Policy
Govt proposes to implement mandatory SAF blending from January 2027
1% mandatory SAF blending proposed for international flights
Mandatory SAF blending proposed in 2 phases
@NDTVProfit
Darius Khambata warns that a Tata Sons listing could threaten Tata Trusts’ governance model, as he opts out of reappointment as trustee.
@nizzgeneration breaks down the key takeaways from Khambata’s letter to Noel Tata, seen by NDTV Profit.
#NimittDixit
Senior advocate Darius Khambata has declined reappointment as trustee of the Sir Dorabji Tata Trust and Sir Ratan Tata Trust, sharply criticising the handling of the Tata Sons governance dispute, the engagement with the Reserve Bank of India over its regulatory status and attempts to separate the holding company from its charitable owners.
@nizzgeneration
https://t.co/YX0P7O3hEF
Tata Sons has infused another Rs 1,100 crore into Tata Electronics amid its restructuring push.
The latest investment follows a Rs 1,500 crore infusion in March, taking the total across the two tranches to Rs 2,600 crore.
@nizzgeneration
https://t.co/FugvyLexxm
#NDTVProfitExclusive | https://t.co/3Gzh5bJrg6 is moving ahead with its IPO plans.
The company has completed investor roadshows across London, Singapore, Hong Kong and Dubai, is aiming to file its UDRHP by end-November, and is targeting a mid-December listing with an issue size of ₹3,000-4,000 crore.
. @Heeraal , in a conversation with Managing Editor @TamannaInamdar discusses details on the Equitas SFB and why the CEO quit along with a timeline.
Watch Live: https://t.co/HbbGaAKeWt
What should Gen Z do with their Diwali bonuses? And why does a 1970s Hollywood blockbuster explain today's markets?
@nizzgeneration caught up with @iRadhikaGupta, MD and CEO of @EdelweissMF, for a freewheeling chat on money, investing, and Spielberg's thriller being the perfect analogy for the current market story.
#Investing #GenZ #Markets #PersonalFinance